WATSON 462
Pill imprint WATSON 462 has been identified as Metoprolol tartrate 50 mg.
Metoprolol is used in the treatment of high blood pressure; heart failure; angina; supraventricular tachycardia; atrial fibrillation (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy.
Metoprolol 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Metoprolol tartrate Images
- Imprint:
-
WATSON 462
- Strength:
- 50 mg
- Color:
- Pink
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
sodium starch glycolate type A potato
magnesium silicate
povidone
magnesium stearate
hypromellose
titanium dioxide
polyethylene glycol
polysorbate 80
D&C Red No. 30
aluminum oxide
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0462
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0317 | Stat RX USA LLC (repackager) |
| 54569-3787 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
More Metoprolol Tartrate resources
- Metoprolol
- Metoprolol Succinate Extended-Release Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Wolters Kluwer)
- Metoprolol Tartrate Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Cerner Multum)
- metoprolol (Cerner Multum)
- metoprolol (Micromedex) - Includes Dosage Information
- metoprolol Intravenous (Micromedex) - Includes Dosage Information
- Metoprolol Succinate (AHFS DI)
- Metoprolol Tartrate (AHFS DI)
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Tartrate Injection (FDA)
- Metoprolol (Wolters Kluwer)


